Stay updated on Resmetirom in NASH and Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Resmetirom in NASH and Fibrosis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page shows a new revision label, v3.6.4, indicating a version update of the page. This update does not modify the study details or the publicly displayed endpoints.
    Difference
    0.0%
    Check dated 2026-07-25T04:42:09.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Steatotic Liver Disease has been added to the glossary, and Fatty Liver Disease has been removed. This reflects a terminology update in how liver conditions are described on the page.
    Difference
    0.0%
    Check dated 2026-07-17T22:18:04.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing v3.6.2, indicating a newer version of the site's software. This update appears to be a backend/platform revision rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-07-03T14:47:30.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page shows a new revision tag v3.6.2, replacing the previous v3.6.0. This indicates a small update to page metadata.
    Difference
    0.0%
    Check dated 2026-06-26T11:27:44.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    New help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was standardized. Recruitment status now indicates No longer looking for participants, and the page revision was updated to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-12T00:22:19.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    New site at St. Luke's Hospital Of Kansas City in Missouri has been added and the study's total locations updated to 247. Tom Hare is now listed as Study Director, and Rebecca Taub, MD is no longer listed.
    Difference
    0.2%
    Check dated 2026-06-05T00:53:02.000Z thumbnail image

Stay in the know with updates to Resmetirom in NASH and Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Resmetirom in NASH and Fibrosis Clinical Trial page.